Reaction
Paracentesis reporting signals
As of the last recalculation, Paracentesis appears in 610 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 296.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 96 | 296.8 | 299.0 |
| Rifaximin | 57 | 102.3 | 102.6 |
| Selexipag | 42 | 59.5 | 59.6 |
| Macitentan | 99 | 58.0 | 58.1 |
| Riociguat | 41 | 45.9 | 46.0 |
| Sildenafil Powder, | 42 | 43.2 | 43.2 |
| Metolazone | 12 | 37.1 | 37.2 |
| Sildenafil | 55 | 35.5 | 35.5 |
| Avapritinib | 9 | 25.7 | 25.7 |
| Bosentan | 34 | 24.3 | 24.3 |
| Sildenafil Citrate | 78 | 23.8 | 23.8 |
| Bumetanide | 17 | 22.6 | 22.6 |
| Trifluridine And Tipiracil | 7 | 22.5 | 22.5 |
| Tadalafil | 58 | 21.7 | 21.7 |
| Rucaparib | 5 | 19.5 | 19.5 |
| Ambrisentan | 61 | 18.4 | 18.4 |
| Treprostinil | 49 | 14.4 | 14.4 |
| Niraparib | 9 | 14.0 | 14.0 |
| Alpelisib | 3 | 11.8 | 11.8 |